Atomera is a semiconductor materials and technology licensing company built around its proprietary Mears Silicon Technology (MST), which aims to improve the performance and power efficiency of transistors. Because the company is still transitioning from engineering-services revenue to commercial royalty agreements, its quarterly results are driven less by top-line sales and more by cash runway, customer progress, and operating-expense discipline. For investors, this report matters as a progress check on whether Atomera can convert technical validation with major chipmakers into repeatable, royalty-bearing license deals. The third-quarter update also arrives amid strong industry demand for advanced logic, memory, and RF components tied to artificial intelligence, raising the stakes for Atomera's GAA, DRAM, and GaN initiatives. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, Atomera reported a net loss of $6.0 million, or ($0.15) per basic and diluted share, compared with a net loss of $5.6 million, or ($0.17) per share, in the third quarter of 2025. Revenue was $0, versus $11,000 in the prior-year quarter and $158,000 in the second quarter of 2026. The ($0.15) per-share loss came in wider than the roughly ($0.12) consensus estimate tracked by market data providers, while revenue of $0 fell short of the approximately $100,000 some analysts had modeled.
Adjusted EBITDA, a non-GAAP measure, was a loss of $4.6 million, compared with a $4.4 million loss a year earlier. The company held $34.8 million in cash, cash equivalents, and short-term investments as of September 30, 2026, and reported 39.1 million shares outstanding. On the operational side, management highlighted an expansion to three GAA customer engagements, a joint development agreement with IQE targeting high-performance, lower-cost RF GaN, and progress on a simpler, lower-cost approach for next-generation DRAM transistors.
The market's response to Atomera's third-quarter update was shaped less by the modest widening of its per-share loss than by the absence of revenue and the pace of commercialization. Reports following the release indicated the stock traded lower as the reported ($0.15) loss per share missed the consensus estimate and revenue came in at $0. For a pre-revenue licensing company, investor sentiment tends to hinge on customer traction and cash runway rather than quarterly earnings alone, and the newly signed IQE joint development agreement and expanded GAA engagements provided some offsetting positives. Net-net, the market appears to be weighing continued technical progress against the reality that meaningful royalty revenue has yet to materialize.
Looking ahead, investors should watch whether Atomera can convert its growing customer engagements into signed joint development agreements and, ultimately, commercial license and royalty contracts. Management has pointed to a broadening pipeline across advanced logic, DRAM, RF GaN, and power applications, but the timing of revenue recognition remains uncertain and largely outside the company's control.
Operating-expense discipline and cash runway will also be in focus. The company ended the quarter with $34.8 million in cash and short-term investments, and management has previously indicated this is sufficient to fund operations for an extended period. Still, rising tool-leasing and service-provider costs flagged on recent calls could pressure the expense base into 2027.
Finally, industry dynamics tied to artificial intelligence and advanced-node transistor scaling remain a key backdrop. Progress in GAA customer evaluations, DRAM cost-reduction efforts, and RF GaN performance milestones will be the clearest signals of whether Atomera's technology is moving closer to revenue-generating adoption.
In my own analysis, I frequently turn to Tickeron’s AI Screener to filter semiconductor names quickly and compare technical patterns alongside fundamentals. It helps surface ideas grounded in data-driven signals without spending hours on manual reviews, which has been useful when tracking pre-revenue names like Atomera.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ATOM moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ATOM as a result. In 78 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ATOM turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 34 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATOM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ATOM entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATOM advanced for three days, in 185 of 240 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ATOM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. ATOM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.168) is normal, around the industry mean (6.788). P/E Ratio (-4.631) is within average values for comparable stocks, (99.275). ATOM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.832). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. ATOM's P/S Ratio (588.235) is very high in comparison to the industry average of (27.093).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATOM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a licensor of proprietary processes for semiconductor industry
Industry ElectronicProductionEquipment